Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 418
New Vaccine Development: Establishing Priorities, Volume II, Diseases of Importance in Developing Countries
Appendix H
Additional Sources of Advice to the Committee
Robert Austrian, The University of Pennsylvania, Philadelphia
Edwin H.Beachey, The University of Tennessee Center for Health Sciences, Memphis, Tenn.
T. Bektimirov, World Health Organization, Geneva, Switzerland
Alan L.Bisno, The University of Tennessee Center for Health Sciences, Memphis, Tenn.
Robert Black, The Johns Hopkins School of Hygiene and Public Health, Baltimore, Md.
Paul A.Blake, Centers for Disease Control, Atlanta, Ga.
Barry R.Bloom, Albert Einstein College of Medicine, Bronx, N.Y.
Claire V.Broome, Centers for Disease Control, Atlanta, Ga.
Donald S.Burke, Walter Reed Army Medical Center, Washington, D.C.
Charles C.J.Carpenter, Case Western Reserve University, Cleveland, Ohio
H.Fred Clark, The Children’s Hospital of Philadelphia, Pa.
Stephen L.Cochi, Centers for Disease Control, Atlanta, Ga.
Floyd W.Denny, The University of North Carolina at Chapel Hill.
Carter L.Diggs, Walter Reed Army Institute of Research, Washington, D.C.
S.Dodu, World Health Organization, Geneva, Switzerland
Richard A.Finkelstein, University of Missouri-Columbia
Donald P.Francis, California State Health Department, Berkeley, Calif.
Carl E.Frasch, Food and Drug Administration, Bethesda, Md.
Roger Glass, National Institutes of Health, Bethesda, Md.
W.Paul Glezen, Baylor College of Medicine, Houston, Tex.
Lance K.Gordon, Connaught Research Institute, Ontario, Canada
Emil C.Gotschlich, Rockefeller University, New York, N.Y.
Dan M.Granoff, Washington University in St. Louis, Mo.
J.McLeod Griffiss, University of California, San Francisco
Stephen C.Hadler, Centers for Disease Control, Atlanta, Ga.
Scott B.Halstead, The Rockefeller Foundation, New York, N.Y.
Harold B.Houser, Case Western Reserve University, Cleveland, Ohio
James B.Kaper, University of Maryland, Baltimore
Myron M.Levine, University of Maryland, Baltimore
Kenneth McIntosh, Boston Children’s Hospital, Boston, Mass.
Thomas P.Monath, Centers for Disease Control, Ft. Collins, Colo.
Arnold S.Monto, University of Michigan, Ann Arbor
OCR for page 419
New Vaccine Development: Establishing Priorities, Volume II, Diseases of Importance in Developing Countries
S.K.Noordeen, World Health Organization, Geneva, Switzerland
Francisco Pinheiro, Pan American Health Organization, Washington, D.C.
Robert H.Purcell, National Institutes of Health, Bethesda, Md.
Arthur L.Reingold, University of California, Berkeley
John B.Robbins, National Institutes of Health, Bethesda, Md.
R.Bradley Sack, The Johns Hopkins University, Baltimore, Md.
Alexis Shelokov, The Johns Hopkins University, Baltimore, Md.
Robert E.Shope, Yale University, New Haven, Conn.
Barbara Stoll, Uniformed University of the Health Sciences, Bethesda, Md.
Joel I. Ward, UCLA School of Medicine, Torrance
William H.Wunner, The Wistar Institute, Philadelphia, Pa.
Richard G.Wyatt, National Institutes of Health, Bethesda, Md.
Representative terms from entire chapter:
western reserve
